Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal drops for preoperative sedation in children with congenital heart disease
ChiCTR2100047472Phase 4Not yet recruiting
- Sponsor
- Henan Provincial People's Hospital
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine in Cardiovascular Malformation (CVM) and anxiety disorder, sponsored by Henan Provincial People's Hospital. Primary endpoint: Mask Acceptance Scale (MAS). Planned start Jun 2021; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Cardiovascular Malformation (CVM)anxiety disorder
Beyond the preview
Go deeper on ChiCTR2100047472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047472.